文献速递血液净化与透析

基于分泌性骨与炎症标志物的数据驱动聚类对血液透析患者进行亚表型分型

Data-Driven Clustering of Secretory Bone and Inflammatory Markers to Subphenotype Patients Undergoing Hemodialysis.
PubMed 文献 · Kidney Int Rep · 2026-08-14

该研究对471例血液透析患者基线8项骨代谢、氧化应激和炎症标志物进行聚类分析,识别出4个亚型,其中炎症-氧化表型1年死亡率最高且对事件预测有增量价值。结论提示多维标志物聚类可捕捉CKD-MBD异质性并区分死亡风险。

要点

  • 血液透析患者可聚类为4个骨-炎症亚型,各亚型预后不同。
  • 炎症-氧化表型伴高主动脉钙负荷和血管病,1年死亡率最高。
  • 聚类分型对事件预测的改善超越临床协变量。

核心结论

  • 多维生物标志物聚类可捕捉CKD-MBD骨与血管疾病表型异质性并区分死亡风险。
  • 炎症通路可能是值得进一步研究的重要方向。

研究设计与样本

  • 多中心队列计算分析,纳入471例血液透析患者。
  • 采用围绕中心点的划分算法,基于8项基线生物标志物进行聚类。

主要发现

  • 共识别4个聚类:聚类1为高骨转换伴高抗氧化能力和高骨特异性碱性磷酸酶。
  • 聚类2为低骨转换伴高抗氧化能力和高硬化蛋白水平。
  • 聚类3为炎症-氧化表型,1年死亡率最高,伴高主动脉钙负荷、血管病、维生素D降解标志物、低疫苗应答和肝脂肪变性。
  • 聚类4生物标志物谱均衡,1年再分类率最高。
  • 聚类归属可改善事件预测,超越临床协变量。

临床怎么用

  • 可考虑整合骨转换、氧化应激和炎症标志物对血透患者进行风险分层。
  • 识别炎症-氧化表型可能有助于识别高危患者并指导进一步研究。

局限性

  • 原文摘要未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Parathyroid hormone (PTH) remains the primary biomarker used to classify and monitor chronic kidney disease-mineral and bone disorder (CKD-MBD); nonetheless, its reliability for risk stratification and treatment guidance is limited. Multidimensional biomarker clustering that integrates indicators of bone turnover, vascular calcification, inflammatory and oxidative stress may better capture the heterogeneity of clinical phenotypes, improve risk stratification, and inform on new therapeutic approaches in dialysis care. METHODS: We conducted a computational analysis of a multicentric cohort study including 471 patients undergoing hemodialysis. The Partitioning Around Medoids algorithm was used to cluster the cohort by a pathophysiology-based biomarker panel (noxPTH, intact parathyroid hormone [iPTH], osteoprotegerin [OPG], soluble receptor activator of nuclear factor-κB ligand [sRANKL], antioxidative capacity [ImAnOx], oxidative capacity [PerOx], β-Crosslaps [β-CL], and high-sensitivity C-reactive protein [hsCRP]) at baseline. The cluster phenotypes were characterized by anthropometrics, imaging, and clinical data. Cluster-specific outcomes and event patterns were assessed after 1 year. RESULTS: A total of 4 distinct clusters were identified. Cluster 1 reflected a high bone turnover state with high antioxidative capacity and high bone-specific alkaline phosphatase. Cluster 2 showed low bone turnover with high antioxidative capacity and high sclerostin levels. Cluster 3 exhibited an inflammatory-oxidative phenotype and the highest 1-year mortality; cluster membership improved prediction of events beyond clinical covariates. This phenotype was marked by high aortic calcium burden, vascular disease, markers of vitamin D degradation, low vaccine response, and hepatic steatosis. Cluster 4 showed a balanced biomarker profile and the highest rate of reclassification after 1 year. CONCLUSION: Multidimensional biomarker clustering captures heterogeneity in bone and vascular disease phenotypes of CKD-MBD, exhibiting differential mortality risk and event patterns and highlighting inflammation as an important pathway for further studies.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Aberger S, Abu-Hanna A, Stel V, et al. Data-Driven Clustering of Secretory Bone and Inflammatory Markers to Subphenotype Patients Undergoing Hemodialysis. Kidney Int Rep. 2026. PMID: 42834924. doi:10.1016/j.ekir.2026.107019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。